期刊
CELL
卷 167, 期 1, 页码 233-+出版社
CELL PRESS
DOI: 10.1016/j.cell.2016.08.056
关键词
-
资金
- NIH [HD045022, R37-CA084198, HG002668, GM114864]
- Damon Runyon Cancer Foundation Postdoctoral Fellowship
- NARSAD Young Investigator Fellowship
- Helen Hay Whitney Foundation Postdoctoral Fellowship
- HARMONIA grant from the National Science Centre in Poland [UMO-2014/14/M/NZ1/00010]
- Human Frontier Science Program postdoctoral fellowship
Mammalian DNA methylation is a critical epigenetic mechanism orchestrating gene expression networks in many biological processes. However, investigation of the functions of specific methylation events remains challenging. Here, we demonstrate that fusion of Tet1 or Dnmt3a with a catalytically inactive Cas9 (dCas9) enables targeted DNA methylation editing. Targeting of the dCas9-Tet1 or -Dnmt3a fusion protein to methylated or unmethylated promoter sequences caused activation or silencing, respectively, of an endogenous reporter. Targeted demethylation of the BDNF promoter IV or the MyoD distal enhancer by dCas9-Tet1 induced BDNF expression in post-mitotic neurons or activated MyoD facilitating reprogramming of fibroblasts into myoblasts, respectively. Targeted de novo methylation of a CTCF loop anchor site by dCas9-Dnmt3a blocked CTCF binding and interfered with DNA looping, causing altered gene expression in the neighboring loop. Finally, we show that these tools can edit DNA methylation in mice, demonstrating their wide utility for functional studies of epigenetic regulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据